首页> 美国卫生研究院文献>other >Effect of Chronic Escitalopram versus Placebo on Personality Traits in Healthy First-Degree Relatives of Patients with Depression: A Randomized Trial
【2h】

Effect of Chronic Escitalopram versus Placebo on Personality Traits in Healthy First-Degree Relatives of Patients with Depression: A Randomized Trial

机译:一项随机试验:慢性艾司西酞普兰与安慰剂对抑郁症患者的健康一级亲属人格特征的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionThe serotonergic neurotransmitter system is closely linked to depression and personality traits. It is not known if selective serotonin reuptake inhibitors (SSRI) have an effect on neuroticism that is independent of their effect on depression. Healthy individuals with a genetic liability for depression represent a group of particular interest when investigating if intervention with SSRIs affects personality. The present trial is the first to test the hypothesis that escitalopram may reduce neuroticism in healthy first-degree relatives of patients with major depressive disorder (MD).
机译:介绍血清奈奈吉神经递质系统与抑郁和人格特质密切相关。如果选择性的血清素再摄取抑制剂(SSRI)是对神经质的影响,则不知道与其对抑郁症的影响无关。抑郁症遗传责任的健康个体代表了在调查与SSRIS的干预影响人格的情况下的一组特别兴趣。目前的试验是第一个测试亚太经产申察患者可能减少重大抑郁症(MD)健康一级亲属的神经细胞的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号